Á lódáil...
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Russo |
Foilsithe: |
Remedium Group LLC
2018-07-01
|
Sraith: | Медицинский совет |
Ábhair: | |
Rochtain Ar Líne: | https://www.med-sovet.pro/jour/article/view/2529 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|